The Point Prevalence Program (PPP) is a collaborative project between Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG) and the Critical Care Division of The George Institute.

Expressions of Interest (EOIs) are now open for the Day 19, 2027 ANZICS Point Prevalence Program (PPP) Study Day, scheduled for June 2027.

We invite investigators to submit proposals addressing prevalence or processes of care in ICU settings. Proposals may focus on either adult and/or paediatric populations and be submitted using the ANZICS PPP Investigator Proposal Template and PPP Questions Template.

Key Details
• EOI Submission Deadline: Monday 21st September 2026
• Submit to: ppp@georgeinstitute.org.au

Investigator Drop-In Sessions
We’re offering a 15-minute drop-in session (via Teams) for investigators to discuss their proposal ideas directly with the PPP Steering Committee Co-Convenors. This is a great opportunity to receive early feedback and guidance. 

Date & Time:
Friday 4th September 2026 9.30-10.30am & 2-3pm
Friday 11th September 2026 9-10.30am
To book a time slot email: ppp@georgeinstitute.org.au

Resources
• PPP Core Protocol (Page 1 – Page 47)
• PPP Proposal Template (Page 48 – Page 49)
• CRF Questions Template (Page 50)

Each PPP Study Day includes Baseline and Day 28 Outcome Case Report Forms, which collect information on:
• Patient demographics
• Reason for ICU admission/Severity of Illness
• Length of stay
• Status at Day 28

This generic dataset is available in the Core Protocol V9.0, 30 January 2026, Appendix 4 for Investigators. Reviewing the format and style of these forms is strongly encouraged to ensure alignment with PPP methodology.
Previous Study Day topics can also be found in the Core Protocol V9.0, 30 January 2026, Appendix 3.

We look forward to receiving your proposals and supporting the next round of impactful ICU research.

If you have any questions, please contact the PPP team at The George Institute for Global Health via ppp@georgeinstitute.org.au

Ethics Approval: X18-0511 & 2019/ETH07327
EOI Deadline: 21 September 2026